Day: March 4, 2021

Data Supporting Use of Predictive Enrichment Markers for Lumos Pharma’s LUM-201 Therapy in Clinical Trials for Moderate PGHD Published in Journal of the Endocrine Society

Data Analysis Supports Use of Predictive Enrichment Markers in Phase 2b OraGrowtH210 TrialAUSTIN, Texas, March 04, 2021 (GLOBE NEWSWIRE) --...

error: Content is protected !!